This years keynote speaker was Chi Udeh-Momoh, PhD, Professor of Epidemiology and Prevention & Gerontology and Geriatrics at Wake Forest University
In patients with significant beta-cell failureoften those who have had diabetes for many yearsthere may be insufficient insulin-secreting capacity remaining for GLP-1 agonists to stimulate effectively
Zepbound (tirzepatide) injection 0.5 mL 2.5 mg | 5 mg | 7.5 mg | 10 mg | 12.5 mg | 15 mg
About 80% of people taking these medications will experience one or more of these undesirable digestive symptoms, predictably more so at higher doses
Nausea is the most common, affecting 13-18% in most studies, often during dose escalation
By bypassing traditional pharmacy networks, PlexusDx reduces overhead costs and passes savings directly to patients seeking effective weight management without the administrative burden of insurance coverage